Market Place
Veranova: A CDMO that manages complexity with confidence.
X
Please Wait
Applying Filters...
01 Veranova, L.P. (1)
02 Amino Chemicals Ltd (1)
03 Apicore Pharmaceuticals Private Limited (1)
04 Apothecon Pharmaceuticals Pvt Ltd (1)
05 Lonza AG (1)
01 MIGLUSTAT (3)
02 Miglustat (2)
01 India (2)
02 Malta (1)
03 U.S.A (2)
92
PharmaCompass offers a list of Miglustat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Miglustat manufacturer or Miglustat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Miglustat manufacturer or Miglustat supplier.
PharmaCompass also assists you with knowing the Miglustat API Price utilized in the formulation of products. Miglustat API Price is not always fixed or binding as the Miglustat Price is obtained through a variety of data sources. The Miglustat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Miglustat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Miglustat, including repackagers and relabelers. The FDA regulates Miglustat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Miglustat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Miglustat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Miglustat supplier is an individual or a company that provides Miglustat active pharmaceutical ingredient (API) or Miglustat finished formulations upon request. The Miglustat suppliers may include Miglustat API manufacturers, exporters, distributors and traders.
click here to find a list of Miglustat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Miglustat as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Miglustat API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Miglustat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Miglustat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Miglustat NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Miglustat suppliers with NDC on PharmaCompass.
We have 5 companies offering Miglustat
Get in contact with the supplier of your choice:
